Neuroprotective Strategies in Ischemic Brain Injury

Ischaemic brain injury triggers a cascade of pathophysiological events including excitotoxicity, oxidative stress, inflammation and blood–brain barrier disruption, all of which contribute to neuronal death. Neuroprotective strategies aim to interrupt these cascades by targeting key molecular and cellular mechanisms. Approaches under investigation encompass modulation of glutamate receptors to limit excitotoxic calcium influx, activation of endogenous antioxidant pathways to counteract reactive oxygen species, regulation of inflammatory mediators to restrain microglial overactivation, and preservation of endothelial integrity to maintain blood–brain barrier function. Emerging therapies focus on downstream signalling complexes rather than broad receptor blockade, thereby widening the therapeutic window and reducing off-target effects. The translational challenge remains substantial, with preclinical success often failing to replicate in clinical trials. Improving methodological alignment between animal studies and human stroke, alongside mechanistic insights into neuronal death pathways, holds promise for the design of more effective interventions. Ultimately, integrating multi-target regimens and precise delivery methods will be crucial to advancing global clinical care and reducing the burden of stroke-related disability.

Research from Nature Portfolio

Recent work has elucidated how activation of the Nrf2/heme oxygenase-1 pathway confers robust protection against ischaemic insult. A novel small-molecule activator was shown to elevate Nrf2 binding to antioxidant-response elements, upregulate HO-1 expression in neurones and endothelial cells, and reduce infarct volume in rodent middle cerebral artery occlusion models. In vitro, this compound mitigated oxygen–glucose deprivation-induced oxidative damage and apoptosis, effects that were abolished by Nrf2 or HO-1 knockdown. These findings highlight a central endogenous defence mechanism that can be pharmacologically harnessed for ischaemic stroke.

Neuroprotective Strategies in Ischemic Brain Injury publication trend

The graph below shows the total number of articles in neuroprotective strategies in ischemic brain injury across all publications each year (not limited to Nature Index journals).

Technical terms

Excitotoxicity: Neuronal injury caused by excessive activation of glutamate receptors, leading to calcium overload and cell death.

Oxidative stress: Imbalance between production of reactive oxygen species and antioxidant defences, resulting in macromolecular damage.

Reperfusion injury: Tissue damage that occurs when blood supply returns after a period of ischaemia, often mediated by inflammation and oxidative burst.

Neuroinflammation: Activation of glial cells and release of pro-inflammatory mediators in the injured brain, which can exacerbate neuronal loss.

Blood–brain barrier: Endothelial cell junctions and associated structures that regulate molecular passage into the central nervous system and maintain homeostasis.

Apoptosis: Programmed cell death characterised by caspase activation, chromatin condensation and DNA fragmentation in neurones and glia.

References

1. Targeting NMDA receptors in stroke: new hope in neuroprotection. Molecular Brain (2018).
2. Attenuation of acute stroke injury in rat brain by minocycline promotes blood–brain barrier remodeling and alternative microglia/macrophage activation during recovery. Journal of Neuroinflammation (2015).
3. Neuroprotection by Acetyl-11-Keto-β-Boswellic Acid, in Ischemic Brain Injury Involves the Nrf2/HO-1 defense Pathway. Scientific Reports (2014).
4. Neuronal Death Mechanisms and Therapeutic Strategy in Ischemic Stroke. Neuroscience Bulletin (2022).
5. Nrf2 Regulates Oxidative Stress and Its Role in Cerebral Ischemic Stroke. Antioxidants (2022).
6. Neuroprotection for Stroke: Current Status and Future Perspectives. International Journal of Molecular Sciences (2012).